DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR (Abst.) DMTs in pediatric-onset MS
       0 replies
   DIR Dr. Aaron Boster rates MS drugs by his opinion of their efficacy
       0 replies
   DIR Frexalimab
       1 replies
   DIR (ACTRIMS) Evobrutinib fails to beat teriflunomide in relapsing...
       0 replies
   DIR (Abst.) Navigating the discontinuation of MS first-line treatm...
       0 replies
   DIR (NEJM) Inhibition of CD40L with frexalimab in MS
       1 replies
   DIR (JAMA Neurology) Highly effective therapies as first-line trea...
       0 replies
   DIR (Abst.) Risk of cervical abnormalities for women w/MS treated ...
       0 replies
   DIR Safety monitoring of disease-modifying therapies in MS
       0 replies
   DIR Real-world study gives insights on adverse event profiles of s...
       0 replies
       *****************************************************
   DIR Previous Page
   DIR Next Page